Serum interleukin-1 alpha and soluble interleukin-2 receptor concentrations in cystic fibrosis.
AUTOR(ES)
Greally, P
RESUMO
Interleukin (IL)-1 and IL-2 may participate in the systemic inflammatory response and hypergammaglobulinaemia observed in patients with cystic fibrosis. Thirty seven patients with cystic fibrosis were compared with 25 normal controls. High IgG and IgM concentrations were associated with more severe pulmonary disease. IL-1 alpha and soluble IL-2 receptor concentrations were higher in the cystic fibrosis group than in the controls and also correlated with concentrations of IgG and IgM. These results suggest that these cytokines may contribute to enhanced immunoglobulin synthesis and silent inflammatory activity in clinically stable patients with cystic fibrosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1029377Documentos Relacionados
- Clinical relevance of raised soluble serum interleukin-2 receptor concentrations in cystic fibrosis.
- Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone.
- Increased concentrations of soluble interleukin-2 receptor in the serum of patients with systemic sclerosis.
- Serum soluble interleukin-2 receptor levels in familial Mediterranean fever.
- Cystic fibrosis. 2. Lung injury in cystic fibrosis.
